Australia markets closed

Kezar Life Sciences, Inc. (KZR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.7657-0.0023 (-0.30%)
At close: 04:00PM EDT
0.7592 -0.01 (-0.85%)
After hours: 06:55PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 55.91M
Enterprise value -105.60M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.97
Price/book (mrq)0.33
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.06

Trading information

Stock price history

Beta (5Y monthly) 0.47
52-week change 3-73.63%
S&P500 52-week change 326.36%
52-week high 33.1300
52-week low 30.6700
50-day moving average 30.8492
200-day moving average 31.0032

Share statistics

Avg vol (3-month) 3810.54k
Avg vol (10-day) 3729.48k
Shares outstanding 572.8M
Implied shares outstanding 672.8M
Float 852.48M
% held by insiders 114.84%
% held by institutions 161.57%
Shares short (30 Apr 2024) 44.15M
Short ratio (30 Apr 2024) 46.28
Short % of float (30 Apr 2024) 45.84%
Short % of shares outstanding (30 Apr 2024) 45.71%
Shares short (prior month 28 Mar 2024) 43.57M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,491.77%

Management effectiveness

Return on assets (ttm)-27.01%
Return on equity (ttm)-48.07%

Income statement

Revenue (ttm)7M
Revenue per share (ttm)0.10
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -103.36M
Net income avi to common (ttm)-101.33M
Diluted EPS (ttm)-1.3900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)179.8M
Total cash per share (mrq)2.47
Total debt (mrq)18.29M
Total debt/equity (mrq)10.81%
Current ratio (mrq)11.48
Book value per share (mrq)2.32

Cash flow statement

Operating cash flow (ttm)-83.65M
Levered free cash flow (ttm)-46.65M